Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Regencell Bioscience Holdings Ltd (NASDAQ: RGC) closed the day trading at $35.17 up 8.08% from the previous closing price of $32.54. In other words, the price has increased by $8.08 from its previous closing price. On the day, 0.58 million shares were traded. RGC stock price reached its highest trading level at $37.991 during the session, while it also had its lowest trading level at $31.73.
Ratios:
For a better understanding of RGC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.39 and its Current Ratio is at 7.39. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.05.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGC now has a Market Capitalization of 17391173632 and an Enterprise Value of 17386821632.
Stock Price History:
The Beta on a monthly basis for RGC is 2.03, which has changed by 255.53964 over the last 52 weeks, in comparison to a change of 0.17287207 over the same period for the S&P500. Over the past 52 weeks, RGC has reached a high of $83.60, while it has fallen to a 52-week low of $0.09. The 50-Day Moving Average of the stock is 79.67%, while the 200-Day Moving Average is calculated to be 130.76%.
Shares Statistics:
Over the past 3-months, RGC traded about 389.52K shares per day on average, while over the past 10 days, RGC traded about 1365670 shares per day. A total of 494.49M shares are outstanding, with a floating share count of 56.59M. Insiders hold about 88.56% of the company’s shares, while institutions hold 0.13% stake in the company. Shares short for RGC as of 1767139200 were 1285978 with a Short Ratio of 3.30, compared to 1764288000 on 1184257. Therefore, it implies a Short% of Shares Outstanding of 1285978 and a Short% of Float of 2.32.
